{"id":"W2035077408","doi":"10.1111/j.1600-0609.2009.01230.x","title":"Rivaroxaban – an oral, direct Factor Xa inhibitor – lessons from a broad clinical study programme","year":2009,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Bayer HealthCare; Bayer","keywords":"Rivaroxaban; Medicine; Dosing; Atrial fibrillation; Stroke (engine); Intensive care medicine; Apixaban; Venous thromboembolism; Internal medicine; Warfarin; Thrombosis","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002316056,0.0005948569,0.005753262,0.0005067215,0.00009335583,0.00009457603,0.0005506545,0.0001992232,0.0001906154],"category_scores_gemma":[0.00128832,0.0003980918,0.001496868,0.0003536816,0.000129924,0.0001663022,0.0001711209,0.001109535,0.0002635937],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006264889,"about_ca_system_score_gemma":0.0003075803,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006201934,"about_ca_topic_score_gemma":0.000007125329,"domain_scores_codex":[0.9901079,0.005064881,0.003341205,0.0005537786,0.0004892599,0.0004429569],"domain_scores_gemma":[0.9952601,0.0005584661,0.00269385,0.0006798051,0.0002880036,0.0005197322],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001827076,0.0003953783,0.004108841,0.0005844197,0.001488553,0.009268863,0.0001448917,1.241564e-7,3.177907e-7,0.00002614371,0.004226668,0.9795731],"study_design_scores_gemma":[0.002398218,0.003903389,0.003457047,0.0028878,0.004485309,0.001393484,0.000125271,8.617228e-7,3.739183e-7,0.00001005826,0.9809974,0.0003407431],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01536031,0.9770303,0.0000653988,0.001127115,0.002634128,0.001989944,0.00003215938,0.0001289244,0.001631661],"genre_scores_gemma":[0.007025322,0.9844033,0.001912803,0.0002246857,0.005531641,0.000001441741,0.0000956417,0.0001691204,0.0006360532],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9792324,"threshold_uncertainty_score":0.9998471,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3931665842578435,"score_gpt":0.5020525776786479,"score_spread":0.1088859934208044,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}